AHCYL1

AHCYL1 Full Name

adenosylhomocysteinase-like 1

AHCYL1 Introduction

AHCYL1 (S-adenosylhomocysteine hydrolase-like protein 1), also known as IRBIT (IP₃ receptor binding protein released with inositol trisphosphate), is a multifunctional protein that belongs to the S-adenosylhomocysteine hydrolase (SAHH) family but lacks enzymatic activity. The gene encoding AHCYL1 is located on human chromosome 1p13.2 and produces a protein of approximately 531 amino acids with a molecular weight of about 59 kDa. AHCYL1 is ubiquitously expressed in human tissues, with the highest levels observed in the brain, kidney, liver, pancreas, and testis. Unlike its enzymatically active homolog AHCY (SAHH), which catalyzes the reversible hydrolysis of S-adenosylhomocysteine to adenosine and homocysteine, AHCYL1 has evolved as a non-catalytic regulatory protein that binds to inositol 1,4,5-trisphosphate (IP₃) receptors and modulates intracellular calcium signaling. It also participates in bicarbonate transport, apoptosis, and cell proliferation. The protein is evolutionarily conserved among vertebrates, highlighting its fundamental biological importance.

Figure 1. Strcuture of AHCYL1.

Structural Domains and Evolutionary Relationship to AHCY
AHCYL1 shares approximately 70% sequence identity with AHCY (S-adenosylhomocysteine hydrolase) but contains critical amino acid substitutions in the active site that abolish its catalytic activity. The protein adopts a similar overall fold to AHCY, consisting of an N-terminal NAD⁺-binding domain, a central catalytic domain, and a C-terminal substrate-binding domain. However, key residues involved in substrate binding and catalysis (such as the cysteine that forms the covalent intermediate in the SAHH reaction) are mutated, rendering AHCYL1 inactive as a hydrolase. Instead, AHCYL1 has acquired unique structural features, including an intrinsically disordered N-terminal region that mediates interactions with IP₃ receptors. This region contains a highly conserved phosphorylation site (Ser71) that regulates its binding affinity. The three-dimensional structure of the AHCYL1-IP₃ receptor complex has not been fully resolved, but structural modeling suggests that the N-terminal region of AHCYL1 binds to the IP₃-binding core of the IP₃ receptor, competing with IP₃ and modulating channel activity.

Regulation of IP₃ Receptors and Calcium Signaling
The primary function of AHCYL1 is to act as an endogenous modulator of inositol 1,4,5-trisphosphate (IP₃) receptors, which are calcium release channels located on the endoplasmic reticulum membrane. Under resting conditions, AHCYL1 binds to the IP₃-binding domain of the IP₃ receptor, preventing spontaneous channel opening. Upon cellular stimulation that generates IP₃, IP₃ competes with AHCYL1 for binding to the receptor, displacing AHCYL1 and allowing IP₃ to activate the channel. This mechanism provides a "clamping" function that sets the threshold for IP₃ receptor activation. AHCYL1 binding also influences the sensitivity of IP₃ receptors to calcium feedback regulation. The interaction is dynamically regulated by phosphorylation; protein kinase A (PKA) and protein kinase C (PKC) phosphorylate AHCYL1 at Ser71, reducing its affinity for IP₃ receptors and facilitating channel activation. Through this regulatory role, AHCYL1 influences diverse calcium-dependent processes, including neurotransmitter release, muscle contraction, cell proliferation, and apoptosis.

Alternate Names for AHCYL1

AHCYL1; adenosylhomocysteinase-like 1; S adenosylhomocysteine hydrolase like 1; putative adenosylhomocysteinase 2; inositol 1; 4; 5 trisphosphate receptor binding protein; IRBIT; XPVKONA; adoHcyase 2